Evidence map›Paper›PMID 40723153›Full record

ArticleCancers2025

Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma.

Simona Miceska, Cvetka Grašič Kuhar, Snježana Frković Grazio, Erik Škof, Praveen Krishnamoorthy, Dineo Khabele, Veronika Kloboves Prevodnik

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Machine Learning-Guided Multi-Cohort Transcriptomic Profiling IdentifiesInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Prognostic value of stromal CD39Scientific reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simona MiceskaDepartment of Cytopathology, Institute of Oncology, Zaloska cesta 2, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1889-1991
Cvetka Grašič KuharFaculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5047-4034
Snježana Frković GrazioDepartment of Pathology, Gynecology Clinic, University Clinical Centre Ljubljana, Šlajmerjeva ulica 3, 1000 Ljubljana, Slovenia.
Erik ŠkofFaculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-7076-4186
Praveen KrishnamoorthyWashington University Center for Cellular Imaging WUCCI, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.ORCID 0000-0003-1459-9344
Dineo KhabeleDepartment of Gynecology and Obstetrics, Washington University School of Medicine in St. Louis, 4911 Barnes Jewish Hospital Plaza, St. Louis, MO 63110, USA.
Veronika Kloboves PrevodnikDepartment of Cytopathology, Institute of Oncology, Zaloska cesta 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0605-6596

Funding

Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer - Diversity SupplementR01CA243511 · NCI · WASHINGTON UNIVERSITY · PI KHABELE, DINEO · 2020 to 2024
$2.5M
NCI NIH HHS R01 CA243511The Slovenian Research and Innovation Agency P3-0289
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

digital-image analysishigh-grade serous ovarian carcinomaimmunohistochemistryinflammation statusmanual scoringprognostic biomarkerstumor-infiltrating lymphocytes

Identifiers

PMID40723153
PMCPMC12293900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.